News

“I wish you the best of luck and groundbreaking research results!” (Vienna, 24.07.2023) Bestselling author Ursula Poznanski in brief: Why she supports the St. Anna Children’s Cancer Research Institute, how she deals with criticism, and what her best decision was! Under the motto of our 35th anniversary “Reaching for the stars”, we interviewed exciting, renowned […]

Successful ERNPaedCan General Assembly (Vienna, 30.06.2023) The St. Anna CCRI team, in collaboration with SIOPE, successfully coordinated this year’s General Assembly for the ERN PaedCan project, marking five years of significant achievements. The assembly functioned as platform to celebrate the progress made and to examine the benefits delivered to patients through the network’s activities. The

With a novel High-Throughput-Screening method the efficacy of numerous drugs can be tested simultaneously. Researchers are now able to quickly and efficiently assess which substances are effective against certain tumors. A team led by Martin Distel, PhD, and Sabine Taschner-Mandl, PhD, of St. Anna Children’s Cancer Research Institute has now provided the first guide on how to use this method to test the sensitivity of childhood tumors to different drugs in zebrafish models. The study was published in the Journal npj Precision Oncology.

Scientists led by Sabine Taschner-Mandl, PhD, St. Anna Children’s Cancer Research Institute, and Nikolaus Fortelny, PhD, Paris Lodron University of Salzburg, are the first to analyze bone marrow metastases from childhood tumors of the nervous system using modern single-cell sequencing analysis. It turns out that cancer cells prevent cells in their environment from fighting the tumor – a process that could be reversed with medication. The findings were published in the renowned journal Nature Communications.

The first-ever ITCC Scientific Days concluded with big success!  The Innovative Therapies for Children with Cancer (ITCC) conference brought together leading international experts and researchers in pediatric oncology to discuss the latest advancements, challenges, and opportunities in understanding and treating pediatric cancers.  Exciting breakthroughs were discussed, including a novel treatment approach for high-grade gliomas that

Prof. Florian Grebien, PhD, is eager to understand why some childhood leukemias show poor treatment response and how this can be tackled. To this end, he is now establishing his own team at St. Anna Children’s Cancer Research Institute (St. Anna CCRI). “Prof. Grebien is an outstanding researcher. We have followed his scientific achievements for many years and are very pleased to have been able to recruit him as a Principal Investigator to St. Anna CCRI,” says Prof. Kaan Boztug, MD, Scientific Director of St. Anna CCRI.

Neuroblastoma Dialogue at ANR Meeting in Amsterdam (Vienna, 26.05.2023) At last week’s Advances in Neuroblastoma Research (ANR) Meeting in Amsterdam, St. Anna CCRI had a strong presence contributing with remarkable talks and posters. Florian Halbritter captivated the audience with his insightful talk on their study titled “Neuroblastoma-associated chromosomal aberrations drive cell identity loss in human neural

Top Talk of the API Conference (Vienna, 19.05.2023) Artem Kalinichenko won the prize for the best talk at the recent API in Germany. His presentation on a genome-wide CRISPR screening approach to identify and study key factors essential for human lymphocyte function stood out for its groundbreaking insights. API (Arbeitsgemeinschaft Pädiatrische Immunologie) is an esteemed

“Children are our future. It’s really important to take care of them.” (Vienna, 11.5.2023) Maria Happel in brief: Why she supports the St. Anna Children’s Cancer Research Institute, how she deals with criticism, and what acting in plays has to do with healing the soul. Under the motto of our 35th anniversary “Reaching for the stars”, we

CLLS 2023 Symposium: Advancements in Childhood Leukemia and Lymphoma Research (Vienna, 07.05.2023) The 13th Biennial Childhood Leukemia and Lymphoma Symposium (CLLS) unfolded in Valencia, where St. Anna CCRI, Labdia, and St. Anna Children’s Hospital actively participated. CLLS is a pivotal platform for fellows, researchers, and junior faculty to share groundbreaking insights into malignant hematological malignancies,

Natural Killer Cell Symposium in Krems (Krems, 04.05.2023) The NK Cell Symposium in Krems was a pivotal gathering spotlighting the role of natural killer (NK) cells in cancer immunotherapy. Researchers from the St. Anna CCRI and other institutions shared their latest findings, emphasizing NK cells’ potential as a powerful tool in combating cancer. The NK

(Vienna, 29.4.2023) Today is International Day of Immunology – a day to raise awareness for the importance of immunology. A recent study from St. Anna Children’s Cancer Research Institute reveals the association between an impaired immune system and the susceptibility to viral infections and cancer in a young patient.

From Now to NEXT: AI-Driven Neuroblastoma Diagnostics (Vienna, 25.04.2023) A follow-up project, aiming to address the urgent need for advanced diagnostic tools in ultra-high-risk pediatric cancer research was funded by the WWTF NEXT Call. By developing a web-based app, Sabine Taschner-Mandl seeks to empower diagnostic laboratories to conduct tests independently, enhancing the precision and speed